251 related articles for article (PubMed ID: 33499880)
1. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
[TBL] [Abstract][Full Text] [Related]
2. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
[TBL] [Abstract][Full Text] [Related]
3. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
[TBL] [Abstract][Full Text] [Related]
4. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
[TBL] [Abstract][Full Text] [Related]
6. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
Murphy SC; Deye GA; Sim BKL; Galbiati S; Kennedy JK; Cohen KW; Chakravarty S; Kc N; Abebe Y; James ER; Kublin JG; Hoffman SL; Richie TL; Jackson LA
PLoS Pathog; 2021 May; 17(5):e1009594. PubMed ID: 34048504
[TBL] [Abstract][Full Text] [Related]
7. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
8. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.
Jongo S; Church LWP; Milando F; Qassim M; Schindler T; Rashid M; Tumbo A; Nyaulingo G; Bakari BM; Athuman Mbaga T; Mohamed L; Kassimu K; Simon BS; Mpina M; Zaidi I; Duffy PE; Swanson PA; Seder R; Herman JD; Mendu M; Zur Y; Alter G; Kc N; Riyahi P; Abebe Y; Murshedkar T; James ER; Billingsley PF; Sim BKL; Richie TL; Daubenberger C; Abdulla S; Hoffman SL
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38194272
[TBL] [Abstract][Full Text] [Related]
9. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Ishizuka AS; Lyke KE; DeZure A; Berry AA; Richie TL; Mendoza FH; Enama ME; Gordon IJ; Chang LJ; Sarwar UN; Zephir KL; Holman LA; James ER; Billingsley PF; Gunasekera A; Chakravarty S; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; K C N; Murshedkar T; DeCederfelt H; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Laurens MB; Plowe CV; Flynn B; Whalen WR; Todd JP; Noor J; Rao S; Sierra-Davidson K; Lynn GM; Epstein JE; Kemp MA; Fahle GA; Mikolajczak SA; Fishbaugher M; Sack BK; Kappe SH; Davidson SA; Garver LS; Björkström NK; Nason MC; Graham BS; Roederer M; Sim BK; Hoffman SL; Ledgerwood JE; Seder RA
Nat Med; 2016 Jun; 22(6):614-23. PubMed ID: 27158907
[TBL] [Abstract][Full Text] [Related]
10. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
[TBL] [Abstract][Full Text] [Related]
12. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
Mo AX; Pesce J; Hall BF
Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
[TBL] [Abstract][Full Text] [Related]
13. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
Front Immunol; 2021; 12():625712. PubMed ID: 33815377
[TBL] [Abstract][Full Text] [Related]
14. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
[TBL] [Abstract][Full Text] [Related]
15. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
[TBL] [Abstract][Full Text] [Related]
16. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans.
Mouwenda YD; Jochems SP; Van Unen V; Betouke Ongwe ME; de Steenhuijsen Piters WA; Stam KA; Massinga Loembe M; Sim BKL; Esen M; Hoffman SL; Kremsner PG; Fendel R; Mordmüller B; Yazdanbakhsh M
JCI Insight; 2024 May; 9(9):. PubMed ID: 38716733
[TBL] [Abstract][Full Text] [Related]
17. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
[TBL] [Abstract][Full Text] [Related]
18. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
Payne RO; Milne KH; Elias SC; Edwards NJ; Douglas AD; Brown RE; Silk SE; Biswas S; Miura K; Roberts R; Rampling TW; Venkatraman N; Hodgson SH; Labbé GM; Halstead FD; Poulton ID; Nugent FL; de Graaf H; Sukhtankar P; Williams NC; Ockenhouse CF; Kathcart AK; Qabar AN; Waters NC; Soisson LA; Birkett AJ; Cooke GS; Faust SN; Woods C; Ivinson K; McCarthy JS; Diggs CL; Vekemans J; Long CA; Hill AV; Lawrie AM; Dutta S; Draper SJ
J Infect Dis; 2016 Jun; 213(11):1743-51. PubMed ID: 26908756
[TBL] [Abstract][Full Text] [Related]
20. Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.
Laurens MB; Berry AA; Travassos MA; Strauss K; Adams M; Shrestha B; Li T; Eappen A; Manoj A; Abebe Y; Murshedkar T; Gunasekera A; Richie TL; Lyke KE; Plowe CV; Kennedy JK; Potter GE; Deye GA; Sim BKL; Hoffman SL
J Infect Dis; 2019 Nov; 220(12):1962-1966. PubMed ID: 31419294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
